Skip to main content
Premium Trial:

Request an Annual Quote

Compugen to Lead $3.7M EC-Funded MAP-Kinase Pathway Consortium

NEW YORK, March 7 (GenomeWeb News) - Compugen announced today it is leading an international consortium to develop a platform to simulate the MAP-kinase pathway.


The European Commission is funding the consortium with €3.1 million ($3.7 million) over three years.


Other consortium members include Aureus Pharma, Consejo Superior de Investigaciones Cientificas, Institut De Recerca Hospital Universitari Vall De Hebron, Instituto Nazionale Tumori, Max Planck Institute for Infection Biology, University of Glasgow, Weizmann Institute of Science, and Arttic Israel.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.